Literature DB >> 21816388

Atrophy of the cholinergic Basal forebrain over the adult age range and in early stages of Alzheimer's disease.

Michel Grothe1, Helmut Heinsen, Stefan J Teipel.   

Abstract

BACKGROUND: The basal forebrain cholinergic system (BFCS) is known to undergo moderate neurodegenerative changes during normal aging as well as severe atrophy in Alzheimer's disease (AD). However, there is a controversy regarding how the cholinergic lesion in AD relates to early and incipient stages of the disease. In vivo imaging studies on the structural integrity of the BFCS in normal and pathologic aging are rare.
METHODS: We applied automated morphometry techniques in combination with high-dimensional image warping and a cytoarchitectonic map of basal forebrain cholinergic nuclei to a large cross-sectional data set of high-resolution magnetic resonance imaging scans, covering the whole adult age range (20-94 years; n = 211) as well as patients with very mild AD (Clinical Dementia Rating = .5; n = 69) and clinically manifest AD (AD; Clinical Dementia Rating = 1; n = 28). For comparison, we investigated hippocampus volume using automated volumetry.
RESULTS: Volume of the BFCS declined from early adulthood on, and atrophy aggravated in advanced age. Volume reductions in very mild AD were most pronounced in posterior parts of the nucleus basalis of Meynert, whereas in AD, atrophy was more extensive and included the whole BFCS. In clinically manifest AD, the diagnostic accuracy of BFCS volume reached the diagnostic accuracy of hippocampus volume.
CONCLUSIONS: Our findings indicate that cholinergic degeneration in AD occurs against a background of age-related atrophy and that exacerbated atrophy in AD can be detected at earliest stages of cognitive impairment. Automated in vivo morphometry of the BFCS may become a useful tool to assess BF cholinergic degeneration in normal and pathologic aging.
Copyright © 2012 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21816388      PMCID: PMC3701122          DOI: 10.1016/j.biopsych.2011.06.019

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  57 in total

Review 1.  Acetylcholine, aging, and Alzheimer's disease.

Authors:  J L Muir
Journal:  Pharmacol Biochem Behav       Date:  1997-04       Impact factor: 3.533

2.  Very mild Alzheimer's disease: informant-based clinical, psychometric, and pathologic distinction from normal aging.

Authors:  J C Morris; D W McKeel; M Storandt; E H Rubin; J L Price; E A Grant; M J Ball; L Berg
Journal:  Neurology       Date:  1991-04       Impact factor: 9.910

3.  The basal nucleus of Meynert revised: the nerve cell number decreases with age.

Authors:  P Lowes-Hummel; H J Gertz; R Ferszt; J Cervos-Navarro
Journal:  Arch Gerontol Geriatr       Date:  1989-01       Impact factor: 3.250

4.  The Clinical Dementia Rating (CDR): current version and scoring rules.

Authors:  J C Morris
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

5.  Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1-Ch6).

Authors:  M M Mesulam; E J Mufson; B H Wainer; A I Levey
Journal:  Neuroscience       Date:  1983-12       Impact factor: 3.590

6.  Aging, Alzheimer's disease, and the cholinergic system of the basal forebrain.

Authors:  P L McGeer; E G McGeer; J Suzuki; C E Dolman; T Nagai
Journal:  Neurology       Date:  1984-06       Impact factor: 9.910

7.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

8.  Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease.

Authors:  S Lehéricy; E C Hirsch; P Cervera-Piérot; L B Hersh; S Bakchine; F Piette; C Duyckaerts; J J Hauw; F Javoy-Agid; Y Agid
Journal:  J Comp Neurol       Date:  1993-04-01       Impact factor: 3.215

9.  Quantitation and three-dimensional reconstruction of Ch4 nucleus in the human basal forebrain.

Authors:  G M Halliday; K Cullen; M J Cairns
Journal:  Synapse       Date:  1993-09       Impact factor: 2.562

10.  Decreased brain choline uptake in older adults. An in vivo proton magnetic resonance spectroscopy study.

Authors:  B M Cohen; P F Renshaw; A L Stoll; R J Wurtman; D Yurgelun-Todd; S M Babb
Journal:  JAMA       Date:  1995-09-20       Impact factor: 56.272

View more
  100 in total

Review 1.  The rationale for deep brain stimulation in Alzheimer's disease.

Authors:  Zaman Mirzadeh; Ausaf Bari; Andres M Lozano
Journal:  J Neural Transm (Vienna)       Date:  2015-10-06       Impact factor: 3.575

Review 2.  Dysregulation of Rab5-mediated endocytic pathways in Alzheimer's disease.

Authors:  Wei Xu; Fang Fang; Jianqing Ding; Chengbiao Wu
Journal:  Traffic       Date:  2018-02-05       Impact factor: 6.215

3.  Cholinergic basal forebrain atrophy predicts amyloid burden in Alzheimer's disease.

Authors:  Stefan Teipel; Helmut Heinsen; Edson Amaro; Lea T Grinberg; Bernd Krause; Michel Grothe
Journal:  Neurobiol Aging       Date:  2013-10-28       Impact factor: 4.673

Review 4.  Viral vectors for therapy of neurologic diseases.

Authors:  Sourav R Choudhury; Eloise Hudry; Casey A Maguire; Miguel Sena-Esteves; Xandra O Breakefield; Paola Grandi
Journal:  Neuropharmacology       Date:  2016-02-21       Impact factor: 5.250

5.  Cognitive Correlates of Basal Forebrain Atrophy and Associated Cortical Hypometabolism in Mild Cognitive Impairment.

Authors:  Michel J Grothe; Helmut Heinsen; Edson Amaro; Lea T Grinberg; Stefan J Teipel
Journal:  Cereb Cortex       Date:  2015-04-02       Impact factor: 5.357

6.  Cortically projecting basal forebrain parvalbumin neurons regulate cortical gamma band oscillations.

Authors:  Tae Kim; Stephen Thankachan; James T McKenna; James M McNally; Chun Yang; Jee Hyun Choi; Lichao Chen; Bernat Kocsis; Karl Deisseroth; Robert E Strecker; Radhika Basheer; Ritchie E Brown; Robert W McCarley
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-02       Impact factor: 11.205

Review 7.  Where attention falls: Increased risk of falls from the converging impact of cortical cholinergic and midbrain dopamine loss on striatal function.

Authors:  Martin Sarter; Roger L Albin; Aaron Kucinski; Cindy Lustig
Journal:  Exp Neurol       Date:  2014-05-05       Impact factor: 5.330

8.  BMP9 ameliorates amyloidosis and the cholinergic defect in a mouse model of Alzheimer's disease.

Authors:  Rebecca M Burke; Timothy A Norman; Tarik F Haydar; Barbara E Slack; Susan E Leeman; Jan Krzysztof Blusztajn; Tiffany J Mellott
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

9.  Cholinergic neurons excite cortically projecting basal forebrain GABAergic neurons.

Authors:  Chun Yang; James T McKenna; Janneke C Zant; Stuart Winston; Radhika Basheer; Ritchie E Brown
Journal:  J Neurosci       Date:  2014-02-19       Impact factor: 6.167

10.  Brain atrophy in primary progressive aphasia involves the cholinergic basal forebrain and Ayala's nucleus.

Authors:  Stefan J Teipel; Wilhelm Flatz; Nibal Ackl; Michel Grothe; Ingo Kilimann; Arun L W Bokde; Lea Grinberg; Edson Amaro; Vanja Kljajevic; Eduardo Alho; Christina Knels; Anne Ebert; Helmut Heinsen; Adrian Danek
Journal:  Psychiatry Res       Date:  2013-12-06       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.